Stocks · Health care · Biological Products, (No Diagnostic Substances)

NEUROCRINE BIOSCIENCES INC

NBIX Clue Score82
United States Fiscal year ends December CIK 0000914475 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Leslie Norwalk V
29 Jul 2026
Director
Exercised, kept
842
$139.43
$117.40K
Darin Lippoldt
8 Jan 2026
Chief Legal Officer
Exercised, kept
3,349
$35.99
$120.53K
Julie Cooke
16 May 2025
Chief Human Resources Officer
Exercised, kept
6,468
$61.82
$399.85K
Eiry Roberts
8 Nov 2024
Chief Medical Officer
Exercised, kept
1
$79.02
$79.02
Eiry Roberts
8 Nov 2024
Chief Medical Officer
Exercised, kept
971
$102.90
$99.92K
Eiry Roberts
8 Nov 2024
Chief Medical Officer
Exercised, kept
1,233
$81.05
$99.93K
Eiry Roberts
8 Nov 2024
Chief Medical Officer
Exercised, kept
5,140
$77.81
$399.94K
Kevin Charles Gorman
13 Feb 2024
Chief Executive Officer
Exercised, kept
2,312
$43.24
$99.97K
Kevin Charles Gorman
13 Feb 2024
Chief Executive Officer
Exercised, kept
2,778
$35.99
$99.98K
Showing 250 of 751 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 649
Amendments (4/A) skipped 16
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 86
Sales straight out of an exercise 306
Sales at will 323
Transactions with no price 0
Shares from compensation/vesting 5,271,191
Sales filed before the plan box existed 321
History held since 16 Jan 2007